Berlin, September 3, 2024 – Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company in the production and distribution of cannabis, recorded revenues of EUR 24.9 million in the period from January 1 to August 30, 2024. This represents an increase of 62% compared to the same period last year (sales revenue from January 1 to August 30, 2023: EUR 15.4 million). This means that Cantourage has generated higher revenues in 2024 to date than in the entire 2023 financial year (total revenues for 2023: EUR 23.6 million).

‍

• Revenue in the period from January 1 to August 30, 2024, at EUR 24.9 million (prior-year period: EUR 15.4 million) – higher than in the entire 2023 fiscal year
• Revenue rose to EUR 4.9 million in August 2024 (same month last year: EUR 1.7 million), exceeding the previous monthly revenue record
• Revenue growth of between 60% and 80% expected for the full year 2024 compared to 2023

‍

Cantourage's strong growth trend – particularly since the partial legalization of cannabis in Germany in April 2024 – is also reflected in the monthly development of sales revenues. Most recently, revenue growth of EUR 4.9 million was achieved in August 2024 (August 2023 revenue: EUR 1.7 million). This represents an increase of 188% compared to the same month last year and a new monthly revenue record. Previously, the highest monthly sales in the company's history were EUR 4.1 million, achieved in June 2024. Cantourage expects business development to remain positive until the end of 2024. For this reason, sales of between EUR 37 million and EUR 43 million are forecast for 2024 as a whole.

‍

Press contact at Cantourage:

Manuel Taverne| taverne@cantourage.com